Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression

Neuropsychopharmacology

Volumn 26, Issue 4, 2002, Pages 489-493

  Zill, Peter ^a,b   Engel, Rolf ^a   Baghai, Thomas C ^a   Juckel, Georg ^a   Frodl, Thomas ^a   Müller Siecheneder, Florian ^a   Zwanzger, Peter ^a   Schüle, Cornelius ^a   Minov, Christo ^a   Behrens, Stefanie ^a   Rupprecht, Rainer ^a   Hegerl, Ulrich ^a   Möller, Hans Jürgen ^a   Bondy, Brigitta ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Association study; Major depression; Norepinephrine; Polymorphisms; Ppromoter

Indexed keywords

NORADRENALIN TRANSPORTER;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; START CODON; TRANSCRIPTION REGULATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CODON; DEPRESSIVE DISORDER; DNA; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POINT MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSYCHIATRIC STATUS RATING SCALES; SYMPORTERS; TRANSCRIPTION, GENETIC;

EID: 0036199343     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00386-4     Document Type: Article

References (19)

1. Monoamine dysfunction and the pathophysiology and treatment of depression
2. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers
3. Manic-depression and the norepinephrine transporter gene
4. CSF monoamine levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity
5. A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene
6. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression
7. Complexity and power in case-control association studies
8. Catecholamine metabolism, depressive illness, and drug response
9. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings
10. Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression
11. Molecular and cellular mechanisms of antidepressant drugs
12. Molecular cloning and organization of the coding region of the human norepinephrine transporter gene
13. Role of norepinephrine in the pathophysiology and treatment of mood disorders
14. Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders
15. To sleep - Perchance to dream of affective disorders
16. TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD
17. Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler
18. Testing linkage disequilibrium between a disease gene and marker loci
19. Model-free analysis and permutation test for allelic associations